In summary, the elevated frequency of FasLhi CD5+ B cells in T1D subjects extends our previous findings to the human disease and begins to shed new light into a previously unappreciated dysregulation of the Fas pathway in T1D subjects. This evidence concerns the gene FAS and type 1 diabetes mellitus.